The Bone And Joint Health Supplements market size is expected to reach $24.12 billion in 2030 at a CAGR of 10.0%, driven by rising prevalence of osteoporosis.
Read More
The Blood Cancer Drugs market size is expected to reach $111.86 billion in 2030 at a CAGR of 7.2%, driven by increasing incidence of blood cancer globally.
Read More
The Blood Based Biomarkers market size is expected to reach $45.5 billion in 2030 at a CAGR of 12.0%, driven by growing cardiovascular disease cases.
Read More
The Blepharitis market size is expected to reach $1.73 billion in 2030 at a CAGR of 12.2%, driven by increasing awareness regarding eye care.
Read More
The Bladder Cancer Drugs market size is expected to reach $8.89 billion in 2030 at a CAGR of 13.2%, driven by rising incidence of bladder cancer cases.
Read More
The Bisphosphonates market size is expected to reach $7.45 billion in 2030 at a CAGR of 5.4%, driven by increasing prevalence of osteoporosis.
Read More
The Bisphosphonate Drug market size is expected to reach $7.04 billion in 2030 at a CAGR of 5.8%, driven by rising prevalence of osteoporosis globally.
Read More
The Bispecific T-Cell Engagers market size is expected to reach $4.18 billion in 2030 at a CAGR of 21.2%, driven by increasing global incidence of cancer.
Read More
The Bi-Specific MAbS market size is expected to reach $21.83 billion in 2030 at a CAGR of 13.5%, driven by rising prevalence of cancer and chronic diseases.
Read More
The Bisoprolol market size is expected to reach $3.26 billion in 2030 at a CAGR of 8.5%, driven by increasing prevalence of hypertension worldwide.
Read More